|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
digiMedical Solutions, Inc.™ (DGMS) Signs Letter of Intent With Guardian Health Systems in Support of $10 Million 2008 Revenue Goal
5/15/2008 11:08:49 AM
DALLAS, TX--(Marketwire - May 15, 2008) - digiMedical Solutions, Inc. (PINKSHEETS: DGMS) today announced the Company has signed a non-binding letter of intent (LOI) with Guardian Health Systems. The terms of the LOI include digiMedical reselling its proprietary Microsoft-based digiRX and digiReauth services in Guardian's existing markets and driving prescription traffic to Guardian's local, company-owned pharmacies. In return, digiMedical will receive a portion of sales from prescriptions that are fulfilled in Guardian pharmacies located throughout Oklahoma and Texas. Additionally, digiMedical will market Guardian's services to its existing network of physicians in the Dallas, Texas, Naples, Florida and Ft. Myers, Florida markets. The Companies also plan to partner as digiMedical explores the prescription compounding market with an emphasis on the growing veterinary sector. Prescription compounding services, which Guardian currently offers, provide more options to physicians for custom prescriptions that are not commercially available.
|
|
|
|
|
|
|
|
|
|
|